Literature DB >> 2390680

Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.

C Richer1, P Mulder, M P Doussau, P Gautier, J F Giudicelli.   

Abstract

1. The interactions between two K+ channel openers, cromakalim and SR 44866 (infused i.v. at equihypotensive doses), and the sympathetic nervous system at the systemic and regional (mesentery, kidney, hindlimb) vascular levels were investigated in the pithed spontaneously hypertensive rat (SHR) by use of the pulsed Doppler technique. 2. The two K+ channel openers did not affect postsynaptic alpha 1- but slightly reduced postsynaptic alpha 2-adrenoceptor mediated systemic pressor and regional vasoconstrictor responses. 3. Both drugs significantly decreased the systemic pressor and regional vasoconstrictor responses elicited by spinal cord stimulation. These sympathoinhibitory effects were not homogeneously distributed among the different vascular beds, the decreasing rank order being: mesentery greater than kidney greater than hindlimb. Simultaneously, the spinal cord stimulation-induced tachycardia remained unaffected. 4. After treatment with K+ channel openers, restoration of initial blood pressure and vascular tone values by infusion of prostaglandin F2 alpha (PGF2 alpha) and vasopressin respectively did not affect and abolished the sympathoinhibitory effects of cromakalim and SR 44866. 5. We conclude that in SHRs the two K+ channel openers that we investigated exert similar sympathohibitory effects which affect some vascular beds more than others. These effects are not dependent upon the arterial blood pressure level and are most likely prejunctionally located.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390680      PMCID: PMC1917799          DOI: 10.1111/j.1476-5381.1990.tb15846.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

2.  Cardiovascular effects of apamin and BRL 34915 in rats and rabbits.

Authors:  N S Cook; R P Hof
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

3.  BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.

Authors:  R E Buckingham; J C Clapham; T C Hamilton; S D Longman; J Norton; R H Poyser
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

4.  An ultrasonic pulsed Doppler system for measuring blood flow in small vessels.

Authors:  C J Hartley; J S Cole
Journal:  J Appl Physiol       Date:  1974-10       Impact factor: 3.531

Review 5.  Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.

Authors:  P A van Zwieten; P B Timmermans; M J Thoolen; B Wilffert; A De Jonge
Journal:  Am J Cardiol       Date:  1986-02-26       Impact factor: 2.778

6.  [Potassium agonists: regional vasodilator profile in rats].

Authors:  C Richer; P Mulder; M P Doussau; J F Giudicelli
Journal:  Arch Mal Coeur Vaiss       Date:  1989-07

7.  Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.

Authors:  R E Buckingham
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

8.  Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.

Authors:  C Richer; F Lefevre-Borg; J Lechaire; C Gomeni; R Gomeni; J F Giudicelli; I Cavero
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

9.  Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein.

Authors:  T C Hamilton; S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

10.  Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.

Authors:  N S Cook; U Quast; R P Hof; Y Baumlin; C Pally
Journal:  J Cardiovasc Pharmacol       Date:  1988-01       Impact factor: 3.105

View more
  3 in total

1.  Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.

Authors:  L J van Woerkens; N R Baas; W J van der Giessen; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

2.  Arterial vasodilating profile and biological effects of pinacidil in healthy volunteers.

Authors:  C Thuillez; E Pussard; E Bellissant; C Richer; R Kechrid; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.

Authors:  N S Cook; I D Chapman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.